Cristina T Rosas

Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.

N. Osterrieder, S. Paessler, H. Ni, 2008, The American journal of tropical medicine and hygiene.

Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins.

M. Beer, N. Osterrieder, E. Dubovi, 2007, The Journal of general virology.

Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.

G. R. Van de Walle, C. Parrish, N. Osterrieder, 2008, Vaccine.

Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

N. Osterrieder, B. Wagner, B. K. Tischer, 2007, Virus research.

Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?

J. von Einem, N. Osterrieder, L. Goodman, 2006, Expert review of vaccines.

A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.

G. R. Van de Walle, N. Osterrieder, Sarah T. Peters, 2010, Vaccine.